AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 264923 — intervention group
Group type: EXPERIMENTAL
Intervention: Two fluoride tablets daily
Number of subjects: 0
Study 264923 — intervention group
Group type: EXPERIMENTAL
Intervention: One fluoride tablet daily
Number of subjects: 0
Study 264923 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet (control group)
Number of subjects: 0
Study 6794081 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 1.6 mg
Number of subjects: 12
Study 6794081 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.8 mg
Number of subjects: 12
Study 6794081 — intervention group
Group type: COMPARATOR
Intervention: Control (no naloxone)
Number of subjects: 12
Study 30782937 — intervention group
Group type: EXPERIMENTAL
Intervention: Education about the risks of driving into floodwater plus a theory‐based behaviour change intervention using planning and imagery exercises
Number of subjects: 0
Study 30782937 — intervention group
Group type: COMPARATOR
Intervention: Education about the risks of driving into floodwater
Number of subjects: 0
Study 28872938 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming
Number of subjects: 41
Study 28872938 — intervention group
Group type: EXPERIMENTAL
Intervention: Football
Number of subjects: 41
Study 28872938 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball
Number of subjects: 41
Study 28872938 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study 26741119 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-Low (SL)
Number of subjects: 21
Study 26741119 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 21
Study 25632742 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuji Powder (WP)
Number of subjects: 70
Study 25632742 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole (5 mg, once daily)
Number of subjects: 70
Study 25632742 — intervention group
Group type: EXPERIMENTAL
Intervention: Both WP and Aripiprazole
Number of subjects: 70
Study 22227558 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone 6 mg/day
Number of subjects: 78
Study 22227558 — intervention group
Group type: EXPERIMENTAL
Intervention: haloperidol 20 mg/day
Number of subjects: 78
Study 22227558 — intervention group
Group type: COMPARATOR
Intervention: normal controls
Number of subjects: 78
Study 20206777 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy (VBT) 21 Gy high-dose rate in three fractions or 30 Gy low-dose rate
Number of subjects: 427
Study 20206777 — intervention group
Group type: COMPARATOR
Intervention: Pelvic external beam radiotherapy (EBRT) 46 Gy in 23 fractions
Number of subjects: 427
Study 20206777 — intervention group
Group type: EXPERIMENTAL
Intervention: VBT
Number of subjects: 427
Study 20206777 — intervention group
Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 427
Study 17353459 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-meter walk test at preferred speed
Number of subjects: 69
Study 17353459 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test at preferred speed
Number of subjects: 69
Study 17353459 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-meter walk test at maximum speed
Number of subjects: 69
Study 17353459 — intervention group
Group type: COMPARATOR
Intervention: 6-minute walk test
Number of subjects: 69
Study 15652681 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ donation education program
Number of subjects: 2868
Study 15652681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education program)
Number of subjects: 2868
Study 12020988 — intervention group
Group type: EXPERIMENTAL
Intervention: VTHR group (HR recorded at the gas exchange ventilatory threshold)
Number of subjects: 24
Study 12020988 — intervention group
Group type: COMPARATOR
Intervention: KHR group (HR according to Karvonen formula)
Number of subjects: 24
Study 12020988 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 10454271 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk (BM)
Number of subjects: 40
Study 10454271 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing only 18-carbon polyunsaturated fatty acids (A)
Number of subjects: 40
Study 10454271 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula enriched with long chain (LC) PUFA (B)
Number of subjects: 40
Study 10454271 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula groups (A and B)
Number of subjects: 40
Study 7598052 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg beta-carotene
Number of subjects: 10
Study 2378704 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure applied after injection of heparin
Number of subjects: 0
Study 2378704 — intervention group
Group type: COMPARATOR
Intervention: Aspiration of the syringe prior to injecting heparin
Number of subjects: 0
Study 2378704 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent injections with pressure applied after injection
Number of subjects: 0
Study 627306 — intervention group
Group type: EXPERIMENTAL
Intervention: Disofrol (dexbrompheniramine maleate + d-isoephedrine sulphate)
Number of subjects: 31
Study 627306 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunerin (brompheniramine + 2-amino-1-phenyl-propanol-(1)-hydrochloride)
Number of subjects: 31
Study 627306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 29843238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (My Mind Project)
Number of subjects: 321
Study 29843238 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 321
Study 27025688 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy to the quadriceps
Number of subjects: 74
Study 27025688 — intervention group
Group type: COMPARATOR
Intervention: Control group (resting in sitting)
Number of subjects: 74
Study 24697702 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathing Without a Battle intervention
Number of subjects: 240
Study 23489856 — intervention group
Group type: EXPERIMENTAL
Intervention: Three one-hour curriculum sessions on consecutive days
Number of subjects: 197
Study 19842168 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT) alone
Number of subjects: 63
Study 19052401 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil (EPO) 500 mg capsules
Number of subjects: 50
Study 19052401 — intervention group
Group type: COMPARATOR
Intervention: Placebo (300 mg sunflower oil capsules)
Number of subjects: 50
Study 16895645 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine direct flushing of endometrial cavity with culture media (group 1)
Number of subjects: 240
Study 16895645 — intervention group
Group type: COMPARATOR
Intervention: Cervical flushing without intrauterine flushing (group 2)
Number of subjects: 240
Study 12804030 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereo audio reproduction
Number of subjects: 45
Study 12804030 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-channel audio reproduction
Number of subjects: 45
Study 12804030 — intervention group
Group type: COMPARATOR
Intervention: Mono audio reproduction
Number of subjects: 45
Study 10737700 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (APO) stimulation
Number of subjects: 15
Study 10737700 — intervention group
Group type: COMPARATOR
Intervention: Saline administration
Number of subjects: 15
Study 9184611 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (200 mg/day for Days 1-7; 400 mg/day for Days 8-56)
Number of subjects: 44
Study 9184611 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day for Days 1-56)
Number of subjects: 44
Study 9184611 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Nefazodone and Fluoxetine
Number of subjects: 44
Study 8473650 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP
Number of subjects: 29
Study 8473650 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAN
Number of subjects: 29
Study 8473650 — intervention group
Group type: COMPARATOR
Intervention: Unpaired trials
Number of subjects: 29
Study 8473650 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 29
Study 3513528 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg guanfacine
Number of subjects: 362
Study 3513528 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg guanfacine
Number of subjects: 362
Study 3513528 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg guanfacine
Number of subjects: 362
Study 3513528 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg guanfacine
Number of subjects: 362
Study 3513528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment defined by presenting visual acuity less than or equal to 6/18 in the better eye
Number of subjects: 4106
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment defined by presenting visual acuity of 6/18 in at least one eye
Number of subjects: 4106
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment defined by presenting visual acuity of 6/12 in the worse eye
Number of subjects: 4106
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment defined by presenting visual acuity of 6/12 in the better eye
Number of subjects: 4106
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Causes of visual impairment
Number of subjects: 4106
Study 29166704 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution of visual impairment in children from low-income families
Number of subjects: 4106
Study 26894832 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mm focal length
Number of subjects: 45
Study 26894832 — intervention group
Group type: COMPARATOR
Intervention: 85 mm focal length
Number of subjects: 45
Study 26894832 — intervention group
Group type: COMPARATOR
Intervention: 105 mm focal length
Number of subjects: 45
Study 26894832 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter focal lengths
Number of subjects: 45
Study 26894832 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall facial shape analysis using GMM
Number of subjects: 45
Study 24210070 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 67
Study 24210070 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 67
Study 23328421 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic education
Number of subjects: 157
Study 23328421 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 157
Study 23328421 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 157
Study 20805340 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal processing of meaninglessness-related words
Number of subjects: 0
Study 20805340 — intervention group
Group type: EXPERIMENTAL
Intervention: Threatened meaning
Number of subjects: 0
Study 18194946 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior intervention, nutritional information and physical exercise
Number of subjects: 59
Study 18194946 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study 15726312 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA-test and DRE advice
Number of subjects: 788
Study 12854359 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg tablet)
Number of subjects: 24
Study 11101019 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme prematurity
Number of subjects: 132
Study 11101019 — intervention group
Group type: COMPARATOR
Intervention: Full-term infants
Number of subjects: 132
Study 8693619 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms twice daily)
Number of subjects: 63
Study 8693619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 1501568 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 18
Study 1501568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6648050 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 10
Study 6648050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31827352 — intervention group
Group type: EXPERIMENTAL
Intervention: Anode placement over the gluteal fold (GF)
Number of subjects: 13
Study 31827352 — intervention group
Group type: COMPARATOR
Intervention: Anode placement midway between the greater trochanter and the lower border of the iliac crest (Midtroc-iliac)
Number of subjects: 13
Study 29219935 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine/morphine (12.5 mg/300 μg)
Number of subjects: 56
Study 29219935 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure and bolus of piritramide (0.1 mg/kg)
Number of subjects: 56
Study 26962830 — intervention group
Group type: EXPERIMENTAL
Intervention: G(120-0) ≥ 2.50 mmol/L or G30 ≥ 9.75 mmol/L
Number of subjects: 1126
Study 26962830 — intervention group
Group type: EXPERIMENTAL
Intervention: High G(120-0) and high G30
Number of subjects: 1126
Study 26962830 — intervention group
Group type: COMPARATOR
Intervention: Diabetes nonconverters
Number of subjects: 1126
Study 26962830 — intervention group
Group type: COMPARATOR
Intervention: Diabetes converters
Number of subjects: 1126
Study 24505327 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (conventional, diffusion tensor, and thalamic proton MR spectroscopy)
Number of subjects: 54
Study 24505327 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental outcomes assessed using Bayley III at 3½ years
Number of subjects: 54
Study 24505327 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarnat staging
Number of subjects: 54
Study 22621162 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% SDF + Peak SE
Number of subjects: 42
Study 22621162 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% SDF + Peak SE
Number of subjects: 42
Study 22621162 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% SDF + Peak LC
Number of subjects: 42
Study 22621162 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% SDF + Peak LC
Number of subjects: 42
Study 22621162 — intervention group
Group type: COMPARATOR
Intervention: Peak SE self‐etch bonding agent
Number of subjects: 42
Study 22621162 — intervention group
Group type: COMPARATOR
Intervention: Peak LC etch‐and‐rinse bonding agent
Number of subjects: 42
Study 22621162 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐etch bonded teeth
Number of subjects: 42
Study 20353111 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with rehabilitation techniques
Number of subjects: 60
Study 20353111 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation techniques only
Number of subjects: 60
Study 17322481 — intervention group
Group type: EXPERIMENTAL
Intervention: Methodical style (33%)
Number of subjects: 156
Study 17322481 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive style (46%)
Number of subjects: 156
Study 17322481 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate style (21%)
Number of subjects: 156
Study 17322481 — intervention group
Group type: COMPARATOR
Intervention: Inadequate style
Number of subjects: 156
Study 15883748 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg, bd, 14 days)
Number of subjects: 40
Study 15883748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15883748 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation
Number of subjects: 40
Study 12201566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.3 mg
Number of subjects: 43
Study 12201566 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin 20 mg
Number of subjects: 43
Study 10442299 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 200 mg i.m. every 2 weeks
Number of subjects: 14
Study 10442299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 7794981 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher self-efficacy
Number of subjects: 79
Study 7794981 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 79
Study 1333518 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cyclophosphamide 400 mg/m2, doxorubicin 40 mg/m2, and cisplatin 40 mg/m2 for six cycles)
Number of subjects: 110
Study 1333518 — intervention group
Group type: COMPARATOR
Intervention: No active treatment (control group)
Number of subjects: 110
Study 1333518 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CAP)
Number of subjects: 110
Study 4001254 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-learning-based treatment
Number of subjects: 66
Study 31509295 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpine climate treatment
Number of subjects: 0
Study 31509295 — intervention group
Group type: COMPARATOR
Intervention: Moderate maritime climate treatment
Number of subjects: 0
Study 29555622 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation gaming group (n=29)
Number of subjects: 90
Study 29555622 — intervention group
Group type: COMPARATOR
Intervention: Entertainment gaming group (n=29)
Number of subjects: 90
Study 29555622 — intervention group
Group type: COMPARATOR
Intervention: Passive control group (n=32)
Number of subjects: 90
Study 25777945 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Falls Assessment Instrument (MFAI) intervention
Number of subjects: 330
Study 25777945 — intervention group
Group type: COMPARATOR
Intervention: Modified version not linked to actions (control)
Number of subjects: 330
Study 24889392 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ornithine (400 mg/day)
Number of subjects: 52
Study 24889392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 22273763 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 11
Study 22273763 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 11
Study 20424614 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet support group after a lecture on the use of the Internet for support and information
Number of subjects: 921
Study 20424614 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 921
Study 18978403 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis management initiated by the orthopaedic team in a specialized orthopaedic osteoporosis clinic
Number of subjects: 62
Study 18978403 — intervention group
Group type: COMPARATOR
Intervention: Usual care managed by primary care physician
Number of subjects: 62
Study 15982429 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic therapy (PediDyne bed)
Number of subjects: 50
Study 15982429 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (manual turning and percussion)
Number of subjects: 50
Study 15982429 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic therapy after standard therapy
Number of subjects: 50
Study 12009344 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel (0.15 mg) plus Ethinyl Estradiol (0.030 mg) daily for 21 days followed by a 7-day rest for 12 months
Number of subjects: 28
Study 12009344 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone Acetate (2 mg) plus Ethinyl Estradiol (0.035 mg) daily for 21 days followed by a 7-day rest for 12 months
Number of subjects: 28
Study 9629401 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 60 mg/day
Number of subjects: 45
Study 9629401 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg/day
Number of subjects: 45
Study 9629401 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 60 mg/day plus Flunarizine 10 mg/day
Number of subjects: 45
Study 9629401 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (Propranolol, Flunarizine, Both)
Number of subjects: 45
Study 9629401 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (alone or associated with Propranolol)
Number of subjects: 45
Study 8198246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic sodium cromoglycate 2% four times daily
Number of subjects: 339
Study 8198246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic sodium cromoglycate 4% twice daily
Number of subjects: 339
Study 8198246 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye-drops twice daily
Number of subjects: 339
Study 2454378 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg
Number of subjects: 30
Study 2454378 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg
Number of subjects: 30
Study 2454378 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 80 mg x 2
Number of subjects: 30
Study 2454378 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (both doses)
Number of subjects: 30
Study 29090475 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense method for plaque control - daily powered tooth brushing with 1% Chlorhexidine gel
Number of subjects: 86
Study 29090475 — intervention group
Group type: COMPARATOR
Intervention: Conventional method for plaque control - daily manual tooth brushing with a standardised commercial toothpaste
Number of subjects: 86
Study 29090475 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Conventional and Intense)
Number of subjects: 86
Study 29090475 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plaque levels
Number of subjects: 86
Study 29090475 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline functional dependency level
Number of subjects: 86
Study 28595700 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 96
Study 28595700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 25432220 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox
Number of subjects: 0
Study 25432220 — intervention group
Group type: COMPARATOR
Intervention: Air-oxygen
Number of subjects: 0
Study 22247303 — intervention group
Group type: EXPERIMENTAL
Intervention: HCMV-positive infants
Number of subjects: 0
Study 22247303 — intervention group
Group type: EXPERIMENTAL
Intervention: HCMV-positive HIV-exposed infants
Number of subjects: 0
Study 19941334 — intervention group
Group type: EXPERIMENTAL
Intervention: General Health Questionnaire at 3, 6, and 12 months
Number of subjects: 85
Study 19941334 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile at 3, 6, and 12 months
Number of subjects: 85